UBS AM’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$68 Buy
+40
New +$82 ﹤0.01% 4231

Other funds holding IPSC

UBS AM's IPSC Position: Q3 2026 in Review

UBS AM opened a new position in Century Therapeutics (IPSC) in Q3 2026: 40 shares worth $68. The stake represents ﹤0.01% of the portfolio and ranks #4231 among its holdings.

74 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

  • UBS AM held 40 shares of Century Therapeutics worth $68 as of Q3 2026.
  • Century Therapeutics was a new UBS AM position in Q3 2026.
  • Century Therapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4231 holding.
  • 74 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.